Skip to main content
. 2007 Nov 1;40(4):333–337. doi: 10.1016/j.jcv.2007.08.015

Table 1.

Clinical and epidemiological features in SARS patients with (n = 31) or without (n = 124) hMPV co-infection

Characteristics hMPV+ (%) hMPV− (%) p-Value
Age (year) 35.9 ± 14.2 36.5 ± 13.3 NS
Male sex 48.4 35.5 NS
Co-existing medical conditionsa 6.5 25.8 0.027
Linkageb to SARS index ward X 77.4 48.4 0.004
HCWs 74.2 50.8 0.019
Fever 100.0 100.0 NS
Chills 96.0 92.0 NS
Myalgia 87.1 87.8 NS
Cough and coryza 22.6 15.9 NS
SOB 48.4 49.2 NS
Diarrhoea 19.4 22.0 NS
Use of supplemental O2 45.2 46.8 NS
ICU admission 19.4 24.2 NS
Death 6.4 7.3 NS
Initial lymphocyte count, mean ± S.D. (×109 L) 0.92 ± 0.45 0.89 ± 0.38 NS
Nadir lymphocyte count, mean ± S.D. (×109 L) 0.30 ± 0.23 0.31 ± 0.23 NS
Peak LDH, mean ± S.D. (U/L) 552 ± 918 615 ± 2385 NS

hMPV: human metapneumovirus; HCW: health-care workers; ICU: intensive care unit; S.D.: standard deviation; LDH: lactate dehydrogenase; NS: statistically insignificant.

a

hMPV-infected individuals were mostly young, previously healthy HCWs; whereas those without co-infection consisted of a mixed of in-patients and HCWs.

b

Among the seven hMPV-infected patients who had never visited index ward X, four were linked to the emergency room, and two to different medical wards. The last patient was a deployed nurse who looked after the initial batch of sick health-care workers in a separate cohort ward, and subsequently developed symptoms.